Background and Aims: Some studies have indicated that inspiratory muscle training (IMT) in chronic heart failure patients improves inspiratory muscle strength, exercise tolerance and quality of life. However the effect and safety of IMT in heart failure patients during the subacute phase has not been established. The aim of this study was to investigate the effect and safety of short-term IMT in hospitalized patients with heart failure.
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Methods: A total of 24 hospitalized patients were allocated to intervention group or control group. Intervention consists of IMT loaded with 40% of maximal inspiratory pressure (PImax). Control sham intervention consists of loaded with 10% of maximal inspiratory pressure. IMT was supervised by a physical therapist. The patients performed IMT in sets of 30, 2 times a day, 5 times a week, for 2 weeks. Before and after intervention, the following measures were obtained: PImax, knee extensor muscle strength (KEMS), six-minute walk distance (6MWD), Borg Scale after sixminute walk test, and the signs of heart failure exacerbation (Body weight, LVEF, BNP, and CTR). The effect of intervention between groups, the effect of time, and the effect of group × time interactions were evaluated using split-plot-factorial analysis of variance.
Results: Short-term IMT resulted in a significantly higher benefit in PImax (P < .05), dyspnoea (P < .05). In both intervention and control groups, heart failure didn't exacerbated by 2-week IMT.
Conclusion:
These results suggest that IMT in patients with heart failure during the subacute phase is safe and effective for improving inspiratory muscle strength and dyspnoea on exertion. an increased risk of many adverse outcomes, but its association with the risk of developing non-alcoholic fatty liver disease (NAFLD) is unclear. Our aim was to investigate whether baseline lung function is associated with incident NAFLD in middle-aged healthy Koreans.
Methods: A cohort study was undertaken in 96,104 healthy subjects (mean age: 35.7 years) without NAFLD. Subjects were followed up annually or biennially from 2002 to 2015. The presence of fatty liver at baseline and at follow-up was determined using ultrasound. Baseline percent predicted forced expiratory volume in one second (FEV1%) and forced vital capacity (FVC%) were categorized in quartiles. Adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) (using the highest quartile as reference) were calculated for incident NAFLD at follow-up, controlling for covariates and potential confounders.
Results: During 579,714.5 person-years of follow-up, 24,450 participants developed NAFLD (incidence rate, 42.2 per 1,000 person-years). The mean follow-up period was 5.9 AE 3.4 years. Regardless of smoking history, the risk for incident NAFLD increased with decreasing quartiles of FEV1 (%) and FVC (%) in a dose-response manner (P for trend < 0.001).
In never smokers, the aHRs (95% CIs) for incident NAFLD were 1.15 (1.08-1.21), 1.11 (1.05-1.18), and 1.08 (1.02-1.14) in quartiles 1-3 for FEV1 (%) and 1.12 (1.06-1.18), 1.11 (1.05-1.18), and 1.09 (1.03-1.15) in quartiles 1-3 for FVC (%), compared with the highest quartile reference.
Reduced lung function was a risk factor for incident NAFLD in a large middle-aged Korean cohort with over half a million person-years of follow-up, regardless of smoking history, measures of obesity/central obesity, and other potential confounders. 
